129
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Inflammatory Burden Index: Association Between Novel Systemic Inflammatory Biomarkers and Prognosis as Well as in-Hospital Complications of Patients with Aneurysmal Subarachnoid Hemorrhage

, , , , ORCID Icon, , , , , , , , , , & ORCID Icon show all
Pages 3911-3921 | Received 08 Apr 2023, Accepted 04 Aug 2023, Published online: 04 Sep 2023
 

Abstract

Purpose

Systemic inflammation plays an important role in the pathophysiology and progression of aneurysmal subarachnoid hemorrhage (aSAH). In this study, we aimed to investigate the association between a new biomarker, the inflammatory burden index (IBI) and the prognosis as well as in-hospital complications of aSAH patients.

Patients and Methods

We analyzed data from patients with aSAH between January 2019 and September 2022 who were included in the LongTEAM (Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage) registry study. The IBI was formulated as C-reactive protein × neutrophils/lymphocytes. The unfavorable functional prognosis was assessed by the modified Rankin Scale (mRS). Receiver operating characteristic (ROC) curve analysis was conducted to determine the optimal cut-off values for IBI to distinguish the unfavorable functional prognosis. Multivariate logistic regression was applied to investigate the association between IBI and in-hospital complications. Propensity score matching was adjusted for imbalances in baseline characteristics to assess the effect of IBI on prognosis.

Results

A total of 408 consecutive patients with aSAH enrolled in the study, of which 235 (57.6%) were female patients and the mean age was 55.28 years old. An IBI equal to 138.03 was identified as the best cut-off threshold to distinguish the unfavorable prognosis at 3 months (area under the curve [AUC] [95% CI] 0.637 [0.568–0.706]). ln IBI was independently associated with 3-month functional prognosis (OR [95% CI] 1.362 [1.148–1.615]; P<0.001), pneumonia (OR [95% CI] 1.427 [1.227–1.659]; P<0.001) and deep venous thrombosis (DVT). (OR [95% CI] 1.326 [1.124–1.564]; P=0.001). After propensity score matching (57:57), an increased proportion of patients with IBI ≥138.03 had a poor functional prognosis at 3 months and in-hospital complications including developed pneumonia and DVT.

Conclusion

In patients with aSAH, high IBI level at admission was associated with unfavorable functional prognosis as well as pneumonia and deep vein thrombosis.

Data Sharing Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Ethics Approval

This study has obtained approval from the Institutional Review Board of Beijing Tiantan Hospital (KY 2021-008-01). Informed consent for clinical analysis was obtained from all individual participants or their authorized representatives. All the analysis was performed according to the Declaration of Helsinki and the local ethics policies.

Acknowledgments

We acknowledge the contribution of all staff who participated in the present study.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors have no personal, financial, or institutional interest in any of the materials or methods used in this study or the findings specified in this paper.

Additional information

Funding

This study was supported by the National Key Research and Development Program of China (Grant Nos. 2021YFC2501101 and 2020YFC2004701), Beijing Municipal Administration of Hospitals Incubating Program, Beijing, China (Grant No. pX2020023), and the Natural Science Foundation of Beijing, China (Grant No. 7204253).